Literature DB >> 2930437

Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze.

E D Levin1, S R McGurk, D South, L L Butcher.   

Abstract

Acetylcholine (ACh) systems have been found to be crucial for the maintenance of accurate cognitive performance. A great variety of studies have shown that the muscarinic ACh receptor blocker scopolamine impairs choice accuracy in the radial-arm maze. Recently, it has been found that the nicotinic ACh receptor blocker mecamylamine also impairs radial-arm maze choice accuracy. In the present study, we investigated the effects of combined administration of these two ACh blockers. Scopolamine (0.15 mg/kg) and mecamylamine (10 mg/kg) each moderately impaired choice accuracy. Combined treatment with scopolamine and mecamylamine significantly decreased choice accuracy relative to either drug alone. This combination treatment lowered choice accuracy to chance levels. These data show that nicotinic and muscarinic blockade have at least additive effects in producing an anterograde memory deficit. Concurrent blockade of these two components of ACh systems may provide a better animal model of cognitive impairments due to the loss of cholinergic neurons, such as Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930437     DOI: 10.1016/s0163-1047(89)90917-5

Source DB:  PubMed          Journal:  Behav Neural Biol        ISSN: 0163-1047


  15 in total

1.  Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses.

Authors:  Ricardo Alvarez-Jimenez; Ellen P Hart; Samantha Prins; Marieke de Kam; Joop M A van Gerven; Adam F Cohen; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2018-02-20       Impact factor: 4.335

2.  Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats.

Authors:  M W Decker; M J Majchrzak
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  The ventral hippocampal muscarinic cholinergic system plays a key role in sexual dimorphisms of spatial working memory in rats.

Authors:  Brandon J Hall; Yael Abreu-Villaça; Marty Cauley; Shaqif Junaid; Hannah White; Abtin Kiany; Edward D Levin
Journal:  Neuropharmacology       Date:  2017-01-26       Impact factor: 5.250

4.  Acute and chronic nicotine effects on working memory in aged rats.

Authors:  E D Levin; D Torry
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

5.  Severe Hypoglycemia-Induced Fatal Cardiac Arrhythmias Are Mediated by the Parasympathetic Nervous System in Rats.

Authors:  Candace M Reno; Justin Bayles; Yiqing Huang; Milan Oxspring; Annie M Hirahara; Derek J Dosdall; Simon J Fisher
Journal:  Diabetes       Date:  2019-08-22       Impact factor: 9.461

6.  Effects of disrupting the cholinergic system on short-term spatial memory in rats.

Authors:  J S Andrews; J H Jansen; S Linders; A Princen
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

7.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 8.  Potential therapeutic uses of mecamylamine and its stereoisomers.

Authors:  Justin R Nickell; Vladimir P Grinevich; Kiran B Siripurapu; Andrew M Smith; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2013-04-18       Impact factor: 3.533

9.  The role of nicotinic receptors in the amelioration of cholinesterase inhibitors in scopolamine-induced memory deficits.

Authors:  Takayoshi Masuoka; Chiaki Kamei
Journal:  Psychopharmacology (Berl)       Date:  2009-07-29       Impact factor: 4.530

10.  Synaptic function of cholinergic-specific Chol-1alpha ganglioside.

Authors:  Susumu Ando; Yasukazu Tanaka; Satoru Kobayashi; Fumiko Fukui; Machiko Iwamoto; Hatsue Waki; Tadashi Tai; Yoshio Hirabayashi
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.